ELIZABETH PETITT: Open Payments
NPI 1518279348 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,439 in 21 payments from 12 companies in 2025. Trend: 2023 $64 · 2024 $545 · 2025 $1,439
Food & beverage: $1,439
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $255 |
| Neurocrine BioSciences, Inc. | 4 | $207 |
| Medtronic, Inc. | 1 | $147 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| ARGENX US, INC. | 1 | $123 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| SANOFI-AVENTIS U.S. LLC | 1 | $119 |
| Exact Sciences Corporation | 2 | $99 |
| United Therapeutics Corporation | 2 | $95 |
| E.R. Squibb & Sons, L.L.C. | 2 | $57 |
Products named: INGREZZA, SYMPLICITY G3, AMVUTTRA, VYVGART, DUPIXENT, AREXVY, TZIELD, Cologuard Collection Kit.
Industry payments across OH — which companies pay providers there.
